Financhill
Back

Vertex Pharmaceuticals 10K Form

Buy
60

VRTX
Vertex Pharmaceuticals

Last Price:
316.40
Seasonality Move:
13.39%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive VRTX News And Ratings

See the #1 stock for the next 7 days that we like better than VRTX

VRTX Financial Statistics

Sales & Book Value

Annual Sales: $7.57B
Cash Flow: $901.3M
Price / Cash Flow: 21.42
Annual Sales: $50.77
Price / Book: 6.23

Profitability

EPS (TTM): 12.68000
Net Income (TTM): $3.27B
Gross Margin: $6.67B
Return on Equity: 29.49%
Return on Assets: 22.54%

Vertex Pharmaceuticals Earnings Forecast

Key Vertex Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 31 years for VRTX is 88.06%.
  • The Selling, General & Administrative Expenses for VRTX have been equal to 11.09% of Gross Profit Margin.
  • The Research & Development expenses have been 40.28% of Revenue.
  • The Interest Expense is 2.63% of Operating Income.
  • The Net Earning history of VRTX is 30.92% of Total Revenues.
  • Per Share Earnings over the last 32 years have been positive in 13 years.

Vertex Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Biotechnology
Sector: Healthcare
Current Symbol: VRTX
CUSIP: 92532F
Website: vrtx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 4.7
Quick Ratio: 4.28

Price-to-Earnings

Trailing P/E Ratio: 35.11
Forward P/E Ratio: 19.87

VRTX Technical Analysis vs Fundamental Analysis

Buy
60
Vertex Pharmaceuticals (VRTX) is a Buy

Is Vertex Pharmaceuticals a Buy or a Sell?